Michael A. Berman, Director at CADENCE PHARMACEUTICALS INC (CADX), bought 10,100 shares at $6.10 ($64K) on 2008-05-15, disclosed to the SEC on 2008-05-19.
Open-market purchase of $64k CADX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.10 | 1,000 | $6K | 9.6% |
| 2 | $6.22 | 100 | $622 | 1.0% |
| 3 | $6.24 | 800 | $5K | 7.8% |
| 4 | $6.33 | 600 | $4K | 6.0% |
| 5 | $6.33 | 900 | $6K | 9.0% |
| 6 | $6.33 | 2,900 |
| $18K |
| 28.9% |
| 7 | $6.33 | 3,800 | $24K | 37.8% |
| Total | $6.30 avg | 10,100 | $64K | 100% |
| Filing → |
| MDC | SELL | 2019-09-17 | $290K | — | Filing → |
| MDC | SELL | 2019-09-16 | $408K | — | Filing → |
| MDC | SELL | 2019-09-12 | $391K | — | Filing → |